Shortly after word spread that Fosun Pharma might pawn off its $3.8 billion business Gland, the Indian drugmaker turned to the Bombay Stock Exchange to respond. In a bout of M&A whiplash that boosted ...

MUMBAI, India-- Gland Pharma Limited ("Company" or "Gland Pharma"), a leading Indian pure-play generic injectable pharmaceutical products company, today announced an agreement under which KKR, a ...

Gland Pharma Limited, a generic injectable-focused pharmaceutical company, today announced its financial results for the fourth quarter and year ended on March 31, 2025. The pharmaceutical company has ...

This article first appeared on GuruFocus. Gland Pharma Ltd (NSE:GLAND) is set to release its Q2 2026 earnings on Nov 3, 2025. The consensus estimate for Q2 2026 revenue is $15.56 billion, and the ...

BENGALURU, Nov 29 (Reuters) - China's Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS), opens new tab is considering a sale of Indian drugmaker Gland Pharma Ltd (GLAD.NS), opens new tab, ...

BENGALURU, April 26 (Reuters) - China's Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd GLAD.NS, ET Now tweeted on Wednesday ...

Private equity major KKR is picking up a minority stake in Gland Pharma Ltd, a pure-play generic injectable pharmaceutical products company, for $200 million, in what would be the biggest PE deal as ...